Work

From Guidelines to Practice: Case-Based Teaching Module to Improve MASLD Screening in Diabetes Care for Internal Medicine Residents

Year: 2026

Type: article

Abstract: Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent, yet underrecognized condition with serious, but preventable, complications. The American Association for the Study of Liver Diseases, American Association of Clinical Endocrinology (2022), and American Diabetes Association (2025) recommend MASLD screening for patients with type 2 diabetes, including using the Fibrosis-4 (FIB-4) index for noninvasive risk stratification of those needing further evaluation. Primary care physicians are key to early diagnosis but may be unfamiliar with updated guidelines. Methods: tests. Results: = .01), with 71% reporting screening changes and 76% reporting referral practice changes. Discussion: Targeted interventions improved knowledge of guideline-based MASLD screening, FIB-4 interpretation, and indications for hepatology referral.

Source: MedEdPORTAL

DOI: 10.15766/mep_2374-8265.11586

Authors: Bethina Liu, Chimsom Orakwue, Kara Ryan, Melina I. Manolas, Sonal Kumar

Institutions: Columbia University Irving Medical Center, Weill Cornell Medicine, Weill Cornell Medical Center, Boston University, Boston Medical Center

Language: English

Topic: Innovations in Medical Education

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Weill Cornell Medical College